Working Groups

WG1: Financial models, pull incentives (Rudolf Blankart)

WG2: Drug shortages / Health economics (Stefan Mühlebach)

WG3 (lead KM): Antimycotics (Konrad Mühlethaler)

WG4 Communication working group (Giacomo di Nepi)